About Victor Kouassi

This author has not yet filled in any details.
So far Victor Kouassi has created 153 blog entries.
<br>Addressing the knowledge gaps surrounding AMR infections in neonatal sepsis</br><em> – by Phoebe Williams, Nina Putri and Gayana Gunaratna</em>
17 June 2021

Addressing the knowledge gaps surrounding AMR infections in neonatal sepsis – by Phoebe Williams, Nina Putri and Gayana Gunaratna

more
<br>Rapid diagnostic tests to support clinical trials of antibiotics</br><em> – by Gian Maria Rossolini</em>
2 June 2021

Rapid diagnostic tests to support clinical trials of antibiotics – by Gian Maria Rossolini

more
<br>Will new antibiotic classes solve multidrug resistance?</br><em> – by Michael N. Dudley and Olga Lomovskaya</em>
21 May 2021

Will new antibiotic classes solve multidrug resistance? – by Michael N. Dudley and Olga Lomovskaya

more
<br>Introducing ProMED-AMR, the new ProMED network for antimicrobial resistance</br><em> – by Matthew E. Levison</em>
26 April 2021

Introducing ProMED-AMR, the new ProMED network for antimicrobial resistance – by Matthew E. Levison

more
<br>Causes of antibiotic shortages and the solutions to address them</br><em> – by Enrico Baraldi</em>
10 February 2021

Causes of antibiotic shortages and the solutions to address them – by Enrico Baraldi

more
<br>Monitoring antimicrobial resistance in Ghana: a focus on the hospital environment</br><em> – by Abiola Isawumi and Lydia Mosi</em>
18 January 2021

Monitoring antimicrobial resistance in Ghana: a focus on the hospital environment – by Abiola Isawumi and Lydia Mosi

more
<br>Learning from IPC strategies for COVID-19 to mitigate AMR in rural Nigerian communities</br><em> – by Rachael Osagie</em>
9 December 2020

Learning from IPC strategies for COVID-19 to mitigate AMR in rural Nigerian communities – by Rachael Osagie

more
<br>The antibiotic R&D landscape in Japan</br><em> – by Norio Ohmagari</em>
25 November 2020

The antibiotic R&D landscape in Japan – by Norio Ohmagari

more
<br>Tackling the drug-resistance pandemic – 2020 and beyond</br><em> – by Laura J.V. Piddock</em>
23 November 2020

Tackling the drug-resistance pandemic – 2020 and beyond – by Laura J.V. Piddock

more
<br>Why are new antibacterials failing as commercial products?</br><em> – by Patricia A. Bradford</em>
19 November 2020

Why are new antibacterials failing as commercial products? – by Patricia A. Bradford

more
© All Rights Reserved
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top